Related Experiment Videos
Ampicillin-resistant Hemophilus influenzae type B infections in hospitalized pediatric patients
Abstract:
Thirty-two pediatric patients with invasive Hemophilus influenzae type B (HITB) infections were evaluated according to the frequency of resistant strains and the clinical profile. The incidence of resistant strains was 28% (9/32), all of them due to beta-lactamase-producing bacteria. The rate of ampicillin resistance was significantly higher among patients who had received beta-lactam antibiotics. The initial treatment of HITB infections in our region should therefore include chloramphenicol; the indiscriminate day-to-day use of beta-lactam antibiotics should be reconsidered.
Insights
The study found that 28% of invasive Hemophilus influenzae type B (HITB) infections involved resistant strains, primarily due to beta-lactamase-producing bacteria. Chloramphenicol is recommended for initial HITB treatment, reconsidering beta-lactam antibiotic use.
Area of Science:
- Pediatric Infectious Diseases
- Microbiology
- Antimicrobial Resistance
Background:
- Invasive Hemophilus influenzae type B (HITB) infections pose a significant pediatric health concern.
- Understanding antimicrobial resistance patterns is crucial for effective treatment strategies.
Purpose of the Study:
- To evaluate the frequency of resistant strains in pediatric HITB infections.
- To analyze the clinical profile associated with these resistant strains.
- To inform regional treatment guidelines for HITB infections.
Main Methods:
- Retrospective analysis of 32 pediatric patients with invasive HITB infections.
- Assessment of bacterial susceptibility to antibiotics, focusing on beta-lactamase production.
- Correlation of resistance rates with prior antibiotic exposure.
Main Results:
- A 28% incidence of resistant HITB strains (9 out of 32 patients) was observed.
- All resistant strains identified were beta-lactamase-producing bacteria.
- Ampicillin resistance was significantly higher in patients with a history of beta-lactam antibiotic use.
Conclusions:
- Initial treatment for HITB infections in the studied region should prioritize chloramphenicol.
- The routine and indiscriminate use of beta-lactam antibiotics warrants reconsideration due to rising resistance.
- Surveillance of antimicrobial resistance is essential for adapting treatment protocols.